Exercise and Nutrition for Older Cancer Survivors and Their Support Person: The Vitality Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorDana-Farber Cancer Institute

About this trial

This research study will compare the impact of virtually supervised and unsupervised home-based exercise and diet programs on cognitive and physical function among cancer survivors and support persons. This study will involve a 6-month home-based virtually supervised or unsupervised exercise and diet intervention.

The names of the study interventions involved in this study are:

* Virtually supervised exercise and healthy diet care * Unsupervised exercise and healthy diet care

Eligibility criteria

Qualifiers

Ability to understand and the willingness to sign informed consent prior to any study- related procedures.

Older adults (≥65 years of age); cancer survivors who are at higher risk for developing comorbid conditions related to physical and cognitive function due to age declines.

Completed chemotherapy and/or targeted therapy in the previous 36 months; said treatment exposure negatively impacts cognitive and physical function.

Diagnosed with breast, lung, prostate, or colorectal cancer which are obesity-related cancers with higher risk for developing comorbid conditions related to physical and cognitive function.

Disqualifiers

Adult cancer survivors less than 65 years of age.

Survivors with a TICS score ≤ 22/41

Survivors with a BMI <25 kg/m2 and body fat <35% for people assigned female at birth and <25% for people assigned male at birth.

Survivors currently consuming a Mediterranean Diet or meeting 2 or more out of the following 3 Mediterranean eating pattern goals in the prior 6 weeks: ≥3 servings of vegetables per day, ≥ 3 servings of beans and legumes per week, or ≥ 1 serving of nuts per day.

Trial design

Treatments tested in this trial

  • Supervised Exercise and Diet Program
  • Unsupervised Exercise and Diet Program

Treatment groups

1,528 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Dana-Farber Cancer Institute

Lead sponsor

Patient-Centered Outcomes Research Institute

Collaborator